Overexpression of β-catenin or SOCS3 promoted glioma stem cell growth, whereas GPM6B overexpression in the context of upregulation of β-catenin or SOCS3 markedly attenuated the promoting effect of β-catenin or SOCS3 (Figures 5A,B). Here, GPM6B is linked to central nervous system cancer.